The family of a California man is pursuing a Xarelto wrongful death lawsuit against Janssen Pharmaceuticals alleging his death was due to Xarelto use.

This Xarelto wrongful death lawsuit is being brought by Tammy W., Successor-in-Interest to Richard W. who died as an alleged result of taking Janssen’s blood thinning drug, Xarelto.

Janssen Faces Xarelto Wrongful Death Lawsuit

Richard suffered various injuries after ingesting Xarelto including physical pain and medical expenses, the lawsuit claims.

He experienced life-threatening bleeding, as well as other severe and personal injuries which are permanent and lasting in nature, physical pain and mental anguish, including diminished enjoyment of life, expenses for hospitalization and medical treatment, and loss of earnings, among other damages, Tammy’s lawsuit states.

Tammy claims in this Xarelto wrongful death lawsuit, that Janssen failed to investigate and research the safety profile of their anticoagulant and failed to provide adequate warnings to both the medical community and the public.

She claims that Janssen also failed to failed to provide information about the need for dose adjustments and blood monitoring. The Xarelto wrongful death lawsuit also claims that Janssen failed to disclose the fact that there was no antidote for a Xarelto excessive bleeding event.

According to this Xarelto wrongful death lawsuit, the drug manufacturer, Janssen, failed to provide a boxed warning about the serious bleeding events that have been associated with Xarelto.

Tammy also claims that Janssen not only knew about the problems with Xarelto, but that they over-promoted the drug, spending $11 million in 2013 alone advertising in journals targeted at prescribers and U.S. consumers.

In 2012, Xarelto brought in $658 million in sales worldwide and then over $1 billion the next calendar year.

Tammy claims in this Xarelto wrongful death lawsuit that, “Defendants overstated the efficacy of Xarelto with respect to preventing stroke and systemic embolism, failed to disclose the need for dose adjustments, failed to disclose the need for blood monitoring, and failed to adequately disclose to patients that there is no drug, agent, or means to reverse the anticoagulation effects of Xarelto, and, that such irreversibility could have permanently disabling, life-threatening and fatal consequences.”

Tammy claims that if Richard had known about the problems and serious risks associated with Xarelto, he would have never chosen to use Xarelto.

Tammy’s Xarelto wrongful death lawsuit, on behalf of Richard, brings claims of strict liability, manufacturing defect, design defect, failure to warn, negligence, breaches of express and implied warranty, negligent misrepresentation and fraud, among other claims.

Xarelto Complications

In July 2011, the FDA approved Xarelto for the prevention of DVT (deep vein thrombosis) and PE (pulmonary embolism) in patients that have undergone certain surgeries.

But by June of the next year, over 1,000 serious Xarelto adverse event reports had been reported by consumers to the FDA, including 65 deaths. By the end of 2012, over 2,000 serious adverse reports had been reported by users of Xarelto, including over 150 deaths.

This Xarelto Wrongful Death Lawsuit is Case No. 2:2016cv13303 and is part of the Xarelto MDL, MDL No. 2592, in the U.S. District Court for the Eastern District of Louisiana.